NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.03
+0.21 (1.18%)
Nov 4, 2024, 4:00 PM EST - Market closed
NAMS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 430.71 | 340.45 | 467.73 | 60.38 | 7.86 |
Cash & Short-Term Investments | 430.71 | 340.45 | 467.73 | 60.38 | 7.86 |
Cash Growth | 2.88% | -27.21% | 674.64% | 668.09% | - |
Other Receivables | 5.41 | 1.88 | 2.07 | 4.88 | - |
Receivables | 5.41 | 1.88 | 2.07 | 4.88 | - |
Prepaid Expenses | 9.24 | 4.46 | 8.18 | 1.7 | 1.36 |
Total Current Assets | 445.35 | 346.79 | 477.98 | 66.96 | 9.22 |
Property, Plant & Equipment | 0.79 | 0.1 | 0.15 | 0.22 | 0.01 |
Other Intangible Assets | 0.54 | 0.17 | 0.21 | - | - |
Other Long-Term Assets | 0.01 | 0.04 | 0.16 | - | - |
Total Assets | 446.69 | 347.1 | 478.5 | 67.99 | 9.23 |
Accounts Payable | 5.28 | 16.92 | 11.85 | 7.07 | 0.4 |
Accrued Expenses | 10.19 | 11.4 | 6.12 | 4.1 | 0.76 |
Short-Term Debt | - | - | - | - | 11.65 |
Current Portion of Leases | 0.23 | 0.06 | 0.07 | 0.06 | - |
Current Unearned Revenue | 6.06 | 8.94 | 13.87 | - | - |
Other Current Liabilities | 23.55 | 12.57 | 4.15 | - | - |
Total Current Liabilities | 45.31 | 49.9 | 36.06 | 11.24 | 12.81 |
Long-Term Leases | 0.33 | - | 0.06 | 0.13 | - |
Long-Term Unearned Revenue | 0.22 | 1.02 | 4.79 | - | - |
Other Long-Term Liabilities | 13.39 | 7.79 | 7.52 | - | - |
Total Liabilities | 59.25 | 58.7 | 48.43 | 11.36 | 12.81 |
Common Stock | 11.15 | 10.17 | 10.06 | 0.13 | 0.05 |
Additional Paid-In Capital | 821.61 | 590.77 | 555.63 | 95.26 | 2.45 |
Retained Earnings | -449.75 | -316.97 | -140.04 | -39.44 | -6.08 |
Comprehensive Income & Other | 4.42 | 4.42 | 4.42 | 0.67 | - |
Shareholders' Equity | 387.44 | 288.39 | 430.07 | 56.63 | -3.58 |
Total Liabilities & Equity | 446.69 | 347.1 | 478.5 | 67.99 | 9.23 |
Total Debt | 0.56 | 0.06 | 0.13 | 0.19 | 11.65 |
Net Cash (Debt) | 430.15 | 340.39 | 467.6 | 60.19 | -3.79 |
Net Cash Growth | 2.77% | -27.21% | 676.83% | - | - |
Net Cash Per Share | 4.94 | 4.14 | 24.65 | 5.48 | -0.76 |
Filing Date Shares Outstanding | 90.02 | 89.27 | 81.77 | 11.33 | 5 |
Total Common Shares Outstanding | 90.02 | 82.47 | 81.56 | 11.33 | 5 |
Working Capital | 400.05 | 296.89 | 441.92 | 55.72 | -3.59 |
Book Value Per Share | 4.30 | 3.50 | 5.27 | 5.00 | -0.72 |
Tangible Book Value | 386.9 | 288.22 | 429.86 | 56.63 | -3.58 |
Tangible Book Value Per Share | 4.30 | 3.49 | 5.27 | 5.00 | -0.72 |
Machinery | - | - | - | 0.04 | 0.01 |
Source: S&P Capital IQ. Standard template. Financial Sources.